Literature DB >> 14747562

Large-scale identification of disease genes involved in acute myeloid leukemia.

Stefan J Erkeland1, Marijke Valkhof, Claudia Heijmans-Antonissen, Antoinette van Hoven-Beijen, Ruud Delwel, Mirjam H A Hermans, Ivo P Touw.   

Abstract

Acute myeloid leukemia (AML) is a heterogeneous group of diseases in which chromosomal aberrations, small insertions or deletions, or point mutations in certain genes have profound consequences for prognosis. However, the majority of AML patients present without currently known genetic defects. Retroviral insertion mutagenesis in mice has become a powerful tool for identifying new disease genes involved in the pathogenesis of leukemia and lymphoma. Here we have used the Graffi-1.4 strain of murine leukemia virus, which causes predominantly AML, in a screen to identify novel genes involved in the pathogenesis of this disease. We report 79 candidate disease genes in common integration sites (CISs) and 15 genes whose family members previously were found to be affected in other studies. The majority of the identified sequences (60%) were not found in lymphomas and monocytic leukemias in previous screens, suggesting a specific involvement in AML. Although most of the virus integrations occurred in or near the 5' or 3' ends of the genes, suggesting deregulation of gene expression as a consequence of virus integration, 18 CISs were located exclusively within the genes, conceivably causing gene disruption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747562      PMCID: PMC369447          DOI: 10.1128/jvi.78.4.1971-1980.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

Review 1.  Acute myeloid leukemia.

Authors:  B Löwenberg; J R Downing; A Burnett
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

2.  Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1.

Authors:  P Vyas; F A Norris; R Joseph; P W Majerus; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes.

Authors:  J B Hogenesch; K A Ching; S Batalov; A I Su; J R Walker; Y Zhou; S A Kay; P G Schultz; M P Cooke
Journal:  Cell       Date:  2001-08-24       Impact factor: 41.582

4.  Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.

Authors:  M Joosten; P J Valk; Y Vankan; N de Both; B Löwenberg; R Delwel
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

5.  A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.

Authors:  N Aoki; T Matsuda
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 6.  From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

Authors:  L H Butterfield; A Merino; S H Golub; H Shau
Journal:  Antioxid Redox Signal       Date:  1999       Impact factor: 8.401

7.  The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

Authors:  D Grimwade; H Walker; G Harrison; F Oliver; S Chatters; C J Harrison; K Wheatley; A K Burnett; A H Goldstone
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

8.  Overexpression of peroxiredoxin in human breast cancer.

Authors:  D Y Noh; S J Ahn; R A Lee; S W Kim; I A Park; H Z Chae
Journal:  Anticancer Res       Date:  2001 May-Jun       Impact factor: 2.480

Review 9.  Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.

Authors:  D A Largaespada
Journal:  Leukemia       Date:  2000-07       Impact factor: 11.528

10.  Notch signaling enhances survival and alters differentiation of 32D myeloblasts.

Authors:  H T Tan-Pertel; L Walker; D Browning; A Miyamoto; G Weinmaster; J C Gasson
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

View more
  13 in total

Review 1.  Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies.

Authors:  Luiza Handschuh
Journal:  J Oncol       Date:  2019-07-30       Impact factor: 4.375

2.  Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.

Authors:  Anne Ahlmann Nielsen; Annette Balle Sørensen; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences.

Authors:  William Lowther; Korah Wiley; Gilbert H Smith; Robert Callahan
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.

Authors:  Véronique Voisin; Corinne Barat; Trang Hoang; Eric Rassart
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  The common viral insertion site Evi12 is located in the 5'-noncoding region of Gnn, a novel gene with enhanced expression in two subclasses of human acute myeloid leukemia.

Authors:  Eric van den Akker; Yolanda Vankan-Berkhoudt; Peter J M Valk; Bob Löwenberg; Ruud Delwel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Loss-of-function of inositol polyphosphate-4-phosphatase reversibly increases the severity of allergic airway inflammation.

Authors:  Jyotirmoi Aich; Ulaganathan Mabalirajan; Tanveer Ahmad; Anurag Agrawal; Balaram Ghosh
Journal:  Nat Commun       Date:  2012-06-06       Impact factor: 14.919

7.  HAT: hypergeometric analysis of tiling-arrays with application to promoter-GeneChip data.

Authors:  Erdogan Taskesen; Renee Beekman; Jeroen de Ridder; Bas J Wouters; Justine K Peeters; Ivo P Touw; Marcel J T Reinders; Ruud Delwel
Journal:  BMC Bioinformatics       Date:  2010-05-21       Impact factor: 3.169

8.  Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.

Authors:  Ivan Ivetac; Rajendra Gurung; Sandra Hakim; Kristy A Horan; David A Sheffield; Lauren C Binge; Philip W Majerus; Tony Tiganis; Christina A Mitchell
Journal:  EMBO Rep       Date:  2009-03-27       Impact factor: 8.807

Review 9.  Animal models of leukemia: any closer to the real thing?

Authors:  Guerry J Cook; Timothy S Pardee
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 10.  High-throughput insertional mutagenesis screens in mice to identify oncogenic networks.

Authors:  Jaap Kool; Anton Berns
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.